AngioDynamics Inc (ANGO) Q2 2020 earnings call dated Jan. 07, 2020 Corporate Participants: Jim Clemmer -- President, Chief Executive Officer, Director Steve Trowbridge -- Senior Vice
AngioDynamics (NASDAQ: ANGO) Q2 2020 Earnings Call Transcript
Categories
Medical Devices
Boston Scientific Corp (NYSE: BSX) Q4 2019 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q4 2019 Earnings Conference Call February 05, 2020 Corporate Participants: Susie Lisa -- Vice President of Investor Relations Michael
Abiomed Inc (NASDAQ: ABMD) Q3 2020 Earnings Call Transcript
Abiomed Inc (NASDAQ: ABMD) Q3 2020 Earnings Conference Call February 06, 2020 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Scott Leinenweber -- Vice President of Investor Relations, Licensing and Acquisitions
Medtronic PLC (NYSE: MDT) Q3 2020 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q3 2020 Earnings Conference Call Feb. 18, 2020 Corporate Participants: Ryan Weispfenning -- Vice President, Head of Investor Relations Omar Ishrak -- Chairman
Johnson & Johnson (NYSE: JNJ) Q4 2019 Earnings Conference Call Transcript
Johnson & Johnson (NYSE: JNJ) Q4 2019 Earnings Conference Call Jan. 22, 2020 Corporate Participants: Christopher DelOrefice -- Vice President of Investor Relations Alex Gorsky -- Chairman,
10x Genomics, Inc. (NASDAQ: TXG) Q4 2019 Earnings Call Transcript
10x Genomics, Inc. (NASDAQ: TXG) Q4 2019 Earnings Conference Call Final Transcript CORPORATE PARTICIPANTS: Carrie Mendivil -- Investor Relations Serge Saxonov -- Chief Executive Officer, Co-founder Justin
Align Technology (ALGN) stock dips to a 3-year low on pandemic concerns
Align Technology Inc. (NASDAQ: ALGN) stock plunged to a 3-year low of $161.39 on Monday as the global pandemic overshadowed its growth
SmileDirectClub (SDC) stock drops to lowest since IPO amid growth prospects
Shares of SmileDirectClub Inc. (NASDAQ: SDC) plunged over 52% to $7.17 on Thursday, which is the lowest since the initial public offering
Tandem Diabetes (TNDM): Q4 2019 Earnings Snapshot
-- Tandem Diabetes (NASDAQ: TNDM) reported earnings of $0.04 per share in the fourth quarter of 2019, vs $0.05 per share loss expected --
Aethlon Medical (AEMD) Q3 2020 Earnings Snapshot
-- Aethlon Medical (NASDAQ: AEMD) reported third quarter 2020 net loss attributable to company of $820,000 or $0.28 per share vs. a
Boston Scientific Corporation (BSX): Q4 2019 Earnings Snapshot
-- Boston Scientific (NYSE: BSX) reported earnings of $0.46 per share in the fourth quarter of 2019, vs. $0.44 per share expected. -- Total
Stryker (SYK): Q4 2019 Earnings Snapshot
-- Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected. -- Total sales grew
Johnson & Johnson (JNJ) beats Q4 earnings estimates, misses on revenue
Johnson & Johnson (NYSE: JNJ) topped earnings estimates for the fourth quarter of 2019 while revenues fell short of expectations. The shares
Abiomed’s (ABMD) revenue increases 13% in Q2 on higher usage of Impella; reiterates 2020 outlook
Abiomed (NASDAQ: ABMD) reported a 13% growth in second quarter 2020 revenue, boosted by the increased usage of its Impella heart pumps.
Stryker (SYK): Q3 2019 Earnings Snapshot
-- Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected. -- Total revenue grew 10.6%
Abbott Laboratories: Solid product line expected to boost Q3 results
There are few pharmaceutical companies as solid as Abbott Laboratories (NYSE: ABT). Thanks to the two major acquisitions it made a couple
Johnson & Johnson (JNJ) likely to feel the pinch in Q3
Johnson & Johnson (NYSE: JNJ) is slated to release its third-quarter earnings results on Tuesday, October 15, before the market opens. The
Medtronic posts upbeat Q1 results, raises EPS outlook
Irish medical technology firm Medtronic plc (NYSE: MDT) on Tuesday announced results for the first quarter of 2020 that were better than what
Agilent Technologies stock surges on Q3 earnings beat, lifts fiscal outlook
Agilent Technologies (NYSE: A) stock surged above 7% after the bell as the company raised its full-year headline numbers. Third quarter results
Boston Scientific Q2 profit dips 72% but beats estimates
Boston Scientific Corporation (NYSE: BSX) reported a 72% dip in earnings for the second quarter due to higher costs and expenses as well